l-carnitine supplement for dogs BSM Partners // Recent paper review – and betaine supplementation Quinicarn for Dogs and Cats

Pfizer's refocused efforts on danuglipron also ended in a decision to discontinue its development in April 2025 following a review of all available clinical trial data, regulatory input and after a single asymptomatic clinical trial participant exhibited potential drug-induced liver injury that resolved after the drug was withdrawn 25

(2025) Although there is extensive evidence that mechanisms of APAP hepatotoxicity translate to human overdose patients, the vast majority of experiments are performed in young and healthy male mice, which does not reflect the entire spectrum of patients in terms of age, sex, pre-existing conditions, consumption of multiple drugs, etc

Diabetes 71 , 21672181 (2022)

Mol Med Rep 8:737740